Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.

550% d'augmentation des cas de dengue au Brésil

DENGUE. Une augmentation de 550% du nombre de cas de dengue a été enregistrée au Brésil en 2015. Selon le secrétariat à la Santé, cette fièvre tropicale qui se propage par la piqûre du moustique tigre a touché 67.253 personnes dans tout l'Etat de Rio, contre 7.819 en 2014. En tout, ce sont plus d'1,5 million de personnes qui ont été touchées dans le pays lors de la saison épidémique en cours. Des chiffres qui inquiètent les autorités sanitaires brésiliennes qui ont en tête l'organisation des Jeux Olympiques en août 2016 à Rio.

New insights into human cytomegalovirus may lead to development of therapeutic interventions

UMass Medical School study shows that human cytomegalovirus rapidly evolves as it spreads from mother to fetus, and from organ to organ, providing genetic targets for new therapeutics


Cytomegalovirus—a ‘stealth’ pathogen—gains attention in the drug development realm

Cytomegalovirus is sometimes called ‘the stealth virus’ because many people, including more than 50% of adults in the US, harbor the infection. But few individuals ever feel the effects of CMV unless something else squelches their immune system first—such as the immunosuppressing drugs given before a bone marrow transplant. Wherever the virus gains a foothold, it can create serious problems such as pneumonia, unrelenting diarrhea or inflammation in the eye.


Experimental CMV vaccine may be more effective than previous vaccines

An experimental vaccine against human cytomegalovirus infection was found to be safe and more effective than previous vaccines, according to a recent study conducted by scientists at the University of California at Davis.


Human Cytomegalovirus: Silent Killer

Many of us are infected with a virus we'll never clear. While we're healthy, it's nothing to worry about, but when our immune system is suppressed it could kill. To catch the herpes virus human cytomegalovirus (HCMV) you must be exposed to someone who has it. This isn't difficult: it is carried by around 65% of the population. Once in the body, HCMV persists for life owing to its clever ability to avoid our immune system and to go into hiding inside our cells in a latent state. Now, research is identifying changes in these cells that could lead to a new route to eradicating the virus.